.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Cantor Fitzgerald
Accenture
US Department of Justice
Chinese Patent Office
Cerilliant
Fish and Richardson
McKesson
Julphar
McKinsey

Generated: June 27, 2017

DrugPatentWatch Database Preview

Claims for Patent: 8,357,713

« Back to Dashboard

Claims for Patent: 8,357,713

Title:Compounds and compositions and methods of use
Abstract: Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.
Inventor(s): Quart; Barry D. (Encinitas, CA), Girardet; Jean-Luc (San Diego, CA), Gunic; Esmir (San Diego, CA), Yeh; Li-Tain (Irvine, CA)
Assignee: Ardea Biosciences Inc. (San Diego, CA)
Application Number:13/174,568
Patent Claims: 1. A pharmaceutical composition comprising a compound of formula (IV): ##STR00179## or a pharmaceutically acceptable salt, ester, or tautomer thereof.

2. A method of reducing serum uric acid levels in a human, the method comprising administering to the human a composition of claim 1.

3. A method of treating gout in a human, the method comprising administering to the human a composition of claim 1.

4. A method of treating hyperuricemia in a human, the method comprising administering to the human a composition of claim 1.

5. The pharmaceutical composition of claim 1, further comprising a second agent effective for treatment of gout.

6. The pharmaceutical composition of claim 5, wherein the second agent is a URAT 1 inhibitor, a xanthine oxidase inhibitor, a xanthine dehydrogenase, a xanthine oxidoreductase inhibitor, or a combination thereof.

7. The pharmaceutical composition of claim 5, wherein the second agent is allopurinol.

8. The pharmaceutical composition of claim 5, wherein the second agent is febuxostat.

9. The pharmaceutical composition of claim 1, further comprising a pharmaceutically acceptable carrier, diluent, or binder.

10. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is a tablet or capsule.

11. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is a tablet.

12. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is a coated tablet.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Express Scripts
Fuji
Citi
Julphar
Johnson and Johnson
Mallinckrodt
Accenture
Cipla
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot